Tech Company Financing Transactions

Arteaus Therapeutics Funding Round

Arteaus Therapeutics, based in Cambridge, secured $18 million from Atlas Venture and OrbiMed.

Transaction Overview

Announced On
10/19/2011
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Undisclosed
Investors

Atlas Venture (Jean-François Formela)

OrbiMed

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 First St. 303
Cambridge, MA 02141
USA
Email Address
Not Recorded
Overview
Arteaus Therapeutics is a biotechnology development company focused on creating new therapiesto treatmigraine.
Profile
Arteaus Therapeutics LinkedIn Company Profile
Social Media
Arteaus Therapeutics Company Twitter Account
Company News
Arteaus Therapeutics News
Facebook
Arteaus Therapeutics on Facebook
YouTube
Arteaus Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Grayzel
  David Grayzel LinkedIn Profile  David Grayzel Twitter Account  David Grayzel News  David Grayzel on Facebook
Co-Founder
Scott Chappel
  Scott Chappel LinkedIn Profile  Scott Chappel Twitter Account  Scott Chappel News  Scott Chappel on Facebook
VP - Operations
Jennifer Foley
  Jennifer Foley LinkedIn Profile  Jennifer Foley Twitter Account  Jennifer Foley News  Jennifer Foley on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/19/2011: Humedica venture capital transaction
Next: 10/19/2011: Booker venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

Our team works diligently to document every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary